Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.08 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 45.14.
Market Cap
9.08T
Revenue
4.62T
Profits
201.21B
PE Ratio
45.14
Profit Margin
4.36%
Dividend Yield
0.39%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -4.55% | 3,027,360 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 616.50B | -3.66% | 8,222,093 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 454.79B | -2.24% | 6,403,220 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 382.76B | 0.21% | 3,650,859 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 320.56B | -0.44% | 7,832,993 | 65.77B |
| 6 | NVS | Novartis AG | 298.75B | -0.25% | 1,992,047 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 265.22B | -1.13% | 2,175,422 | 61.37B |
| 8 | NVO | Novo Nordisk A/S | 225.46B | 0.06% | 10,598,183 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 214.34B | 0.05% | 2,264,715 | 46.34B |
| 10 | AMGN | Amgen Inc. | 209.21B | - | 3,004,913 | 37.22B |
| 11 | ABT | Abbott Laboratories | 182.75B | -2.21% | 6,398,703 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.99B | -1.09% | 6,724,691 | 29.74B |
| 13 | PFE | Pfizer Inc. | 141.97B | -0.95% | 45,202,445 | 63.32B |
| 14 | DHR | Danaher Corporation | 137.90B | -0.16% | 3,586,327 | 25.11B |
| 15 | CVS | CVS Health Corporation | 134.25B | -0.66% | 6,265,051 | 405.62B |
| 16 | SYK | Stryker Corporation | 133.42B | -1.20% | 2,767,392 | 25.84B |
| 17 | BMY | Bristol-Myers Squibb Company | 132.45B | 2.79% | 18,025,812 | 49.19B |
| 18 | ISRG | Intuitive Surgical, Inc. | 124.70B | -0.04% | 2,173,278 | 11.03B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 122.26B | -0.34% | 798,337 | 12.22B |
| 20 | MDT | Medtronic plc | 109.71B | -2.09% | 7,375,406 | 36.36B |
| 21 | GSK | GSK plc | 103.86B | -2.16% | 5,529,203 | 44.05B |
| 22 | MCK | McKesson Corporation | 101.33B | -2.59% | 554,978 | 403.43B |
| 23 | SNY | Sanofi | 100.71B | -4.37% | 10,203,867 | 55.89B |
| 24 | HCA | HCA Healthcare, Inc. | 85.69B | -3.04% | 1,041,160 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 81.63B | 0.11% | 604,441 | 201.11B |
| 26 | CI | The Cigna Group | 76.10B | -2.97% | 1,856,463 | 282.38B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 75.12B | 6.17% | 1,460,512 | 15.53B |
| 28 | BSX | Boston Scientific Corporation | 68.37B | -0.09% | 25,889,792 | 21.00B |
| 29 | COR | Cencora, Inc. | 60.75B | -2.00% | 752,349 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.26B | -2.82% | 5,394,325 | 28.34B |
| 31 | ARGX | argenx SE | 53.75B | -1.13% | 256,729 | 5.32B |
| 32 | CAH | Cardinal Health, Inc. | 53.18B | -0.89% | 1,132,024 | 250.74B |
| 33 | MDLN | Medline Inc. | 51.39B | -2.40% | 3,380,325 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 50.05B | 1.35% | 3,130,005 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 45.59B | -1.75% | 1,380,868 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.08B | -1.93% | 513,063 | 4.45B |
| 37 | HUM | Humana Inc. | 44.03B | 0.34% | 1,641,941 | 145.68B |
| 38 | HLN | Haleon plc | 43.65B | -1.65% | 15,643,337 | 14.80B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 41.26B | 2.02% | 7,978,674 | 17.32B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.85B | 6.22% | 1,809,547 | - |
| 41 | A | Agilent Technologies, Inc. | 39.18B | -1.13% | 1,605,031 | 7.23B |
| 42 | IQV | IQVIA Holdings Inc. | 39.14B | -3.95% | 1,436,130 | 16.98B |
| 43 | NTRA | Natera, Inc. | 38.62B | 6.24% | 1,184,071 | 2.50B |
| 44 | WAT | Waters Corporation | 37.34B | 0.22% | 613,313 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 35.81B | -1.57% | 221,066 | 5.74B |
| 46 | RPRX | Royalty Pharma plc | 33.99B | -0.27% | 2,846,335 | 2.44B |
| 47 | ALC | Alcon Inc. | 33.93B | -0.06% | 2,454,869 | 10.63B |
| 48 | VEEV | Veeva Systems Inc. | 32.74B | -3.05% | 1,169,601 | 3.32B |
| 49 | ZTS | Zoetis Inc. | 31.87B | -2.44% | 3,804,899 | 9.53B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 31.59B | -2.73% | 5,884,319 | 21.27B |
| 51 | ILMN | Illumina, Inc. | 31.03B | 5.27% | 2,765,962 | 4.49B |
| 52 | BIIB | Biogen Inc. | 30.72B | -0.62% | 892,858 | 10.03B |
| 53 | RMD | ResMed Inc. | 30.08B | -2.67% | 905,911 | 5.54B |
| 54 | CNC | Centene Corporation | 30.05B | -1.59% | 5,090,437 | 180.30B |
| 55 | DXCM | DexCom, Inc. | 28.76B | -0.80% | 4,233,268 | 4.97B |
| 56 | MTD | Mettler-Toledo International Inc. | 27.90B | -0.56% | 203,521 | 4.09B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 27.43B | -28.31% | 9,832,146 | 4.80B |
| 58 | LH | Labcorp Holdings Inc. | 25.87B | 2.73% | 1,205,762 | 14.35B |
| 59 | DGX | Quest Diagnostics Incorporated | 25.86B | -0.39% | 756,569 | 11.56B |
| 60 | PHG | Koninklijke Philips N.V. | 25.75B | 1.30% | 1,576,088 | 20.18B |
| 61 | INCY | Incyte Corporation | 24.93B | -3.23% | 2,628,279 | 5.82B |
| 62 | ROIV | Roivant Sciences Ltd. | 24.83B | 5.02% | 4,555,313 | 8.26M |
| 63 | WST | West Pharmaceutical Services, Inc. | 23.90B | 0.63% | 390,783 | 3.33B |
| 64 | BNTX | BioNTech SE | 23.48B | -0.11% | 1,381,266 | 3.23B |
| 65 | MRNA | Moderna, Inc. | 22.98B | 6.29% | 4,439,949 | 2.23B |
| 66 | STE | STERIS plc | 22.53B | -1.54% | 617,457 | 5.94B |
| 67 | UTHR | United Therapeutics Corporation | 22.32B | 0.21% | 318,907 | 3.17B |
| 68 | INSM | Insmed Incorporated | 22.00B | -1.58% | 3,363,242 | 819.56M |
| 69 | VTRS | Viatris Inc. | 20.68B | -0.34% | 4,599,571 | 14.56B |
| 70 | THC | Tenet Healthcare Corporation | 20.35B | -1.90% | 940,638 | 21.81B |
| 71 | GH | Guardant Health, Inc. | 20.20B | 5.75% | 2,709,425 | 1.18B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 18.65B | 2.61% | 2,170,908 | 3.37B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.37B | -2.25% | 1,594,366 | 8.41B |
| 74 | GMAB | Genmab A/S | 17.44B | 0.42% | 1,666,067 | 3.90B |
| 75 | ASND | Ascendis Pharma A/S | 16.55B | -0.39% | 465,674 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.23B | 0.94% | 728,742 | 4.44B |
| 77 | MEDP | Medpace Holdings, Inc. | 16.14B | -1.13% | 318,294 | 2.78B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.06B | -1.68% | 2,515,637 | 579.96M |
| 79 | DVA | DaVita Inc. | 15.33B | -0.87% | 392,991 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 15.18B | 5.06% | 2,911,930 | 13.65B |
| 81 | SOLV | Solventum Corporation | 15.04B | -1.95% | 1,068,928 | 8.26B |
| 82 | COO | The Cooper Companies, Inc. | 14.17B | -0.56% | 1,407,117 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 14.07B | 1.16% | 2,486,599 | 2.38B |
| 84 | BAX | Baxter International Inc. | 13.82B | 7.99% | 22,670,792 | 11.47B |
| 85 | FMS | Fresenius Medical Care AG | 13.51B | 3.38% | 780,680 | 22.32B |
| 86 | SNN | Smith & Nephew plc | 13.43B | -1.01% | 1,401,674 | 6.16B |
| 87 | ELAN | Elanco Animal Health Incorporated | 13.22B | 0.27% | 4,233,615 | 4.89B |
| 88 | ICLR | ICON Public Limited Company | 12.77B | -7.10% | 1,774,113 | 8.29B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.70B | 27.29% | 4,497,634 | 830.81M |
| 90 | RVTY | Revvity, Inc. | 12.67B | 0.15% | 1,467,750 | 2.90B |
| 91 | PEN | Penumbra, Inc. | 12.58B | -0.09% | 288,598 | 1.45B |
| 92 | ALGN | Align Technology, Inc. | 12.42B | -3.70% | 1,532,716 | 4.14B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.30B | 1.28% | 1,367,151 | 622.01M |
| 94 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 3.17% | 714,354 | 708.24M |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.71B | -1.29% | 1,224,122 | 3.24B |
| 96 | PODD | Insulet Corporation | 11.48B | -2.90% | 1,215,115 | 2.90B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.37B | -9.83% | 1,487,634 | 1.28B |
| 98 | CRL | Charles River Laboratories International, Inc. | 11.30B | -0.08% | 666,295 | 4.03B |
| 99 | TECH | Bio-Techne Corporation | 11.22B | - | 6,051,852 | 1.21B |
| 100 | EHC | Encompass Health Corporation | 11.00B | -2.56% | 393,911 | 6.07B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.92B | 2.60% | 2,091,857 | 105.82M |
| 102 | GMED | Globus Medical, Inc. | 10.89B | -1.42% | 827,420 | 3.10B |
| 103 | KRYS | Krystal Biotech, Inc. | 10.81B | 0.98% | 301,886 | 417.30M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.77B | 4.62% | 1,445,272 | 5.67M |
| 105 | SMMT | Summit Therapeutics Inc. | 10.73B | 5.00% | 3,815,392 | - |
| 106 | ENSG | The Ensign Group, Inc. | 10.34B | -1.68% | 442,747 | 5.49B |
| 107 | MOH | Molina Healthcare, Inc. | 10.14B | -2.17% | 651,388 | 42.47B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.07% | 840,073 | - |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 9.98B | 0.60% | 2,102,819 | 3.50B |
| 110 | GKOS | Glaukos Corporation | 9.94B | 4.24% | 2,387,851 | 612.84M |
| 111 | UHS | Universal Health Services, Inc. | 9.88B | -2.90% | 1,160,667 | 18.11B |
| 112 | HALO | Halozyme Therapeutics, Inc. | 9.88B | 0.02% | 1,976,801 | 1.51B |
| 113 | BRKR | Bruker Corporation | 9.79B | 4.21% | 1,901,845 | 3.46B |
| 114 | HSIC | Henry Schein, Inc. | 9.70B | -0.77% | 1,141,921 | 13.38B |
| 115 | OSCR | Oscar Health, Inc. | 9.41B | 2.16% | 3,284,733 | 13.30B |
| 116 | AVTR | Avantor, Inc. | 9.37B | -3.62% | 17,363,027 | 6.56B |
| 117 | SYRE | Spyre Therapeutics, Inc. | 8.93B | 3.71% | 851,358 | - |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 8.92B | 4.24% | 556,349 | 74.06M |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 8.85B | -1.41% | 2,875,003 | 874.09M |
| 120 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | -0.30% | 2,109,625 | 18.07M |
| 121 | KYMR | Kymera Therapeutics, Inc. | 8.80B | 1.67% | 444,443 | 51.48M |
| 122 | BIO | Bio-Rad Laboratories, Inc. | 8.74B | -0.16% | 151,158 | 2.59B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.58B | 5.75% | 516,295 | 7.46M |
| 124 | QGEN | Qiagen N.V. | 8.57B | -0.86% | 2,370,874 | 2.10B |
| 125 | ATR | AptarGroup, Inc. | 8.54B | -1.73% | 491,733 | 3.93B |
| 126 | HQY | HealthEquity, Inc. | 8.44B | -3.02% | 619,753 | 1.34B |
| 127 | ALKS | Alkermes plc | 8.39B | 3.50% | 2,303,337 | 1.67B |
| 128 | IMVT | Immunovant, Inc. | 8.15B | 2.25% | 668,075 | - |
| 129 | RGEN | Repligen Corporation | 8.10B | 1.68% | 1,032,830 | 785.10M |
| 130 | PCVX | Vaxcyte, Inc. | 8.08B | 5.62% | 817,943 | - |
| 131 | TEM | Tempus AI, Inc. | 7.97B | 6.59% | 7,508,113 | 1.43B |
| 132 | IBRX | ImmunityBio, Inc. | 7.80B | 9.08% | 10,093,595 | 140.98M |
| 133 | LQDA | Liquidia Corporation | 7.72B | -0.02% | 1,452,509 | 288.07M |
| 134 | TGTX | TG Therapeutics, Inc. | 7.59B | 0.09% | 2,850,404 | 700.35M |
| 135 | PACS | PACS Group, Inc. | 7.44B | 1.12% | 841,984 | 5.43B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.25B | -0.74% | 448,997 | 217.17M |
| 137 | GRFS | Grifols, S.A. | 7.17B | 0.61% | 1,127,780 | 8.48B |
| 138 | CHE | Chemed Corporation | 7.07B | -0.85% | 140,114 | 2.60B |
| 139 | COGT | Cogent Biosciences, Inc. | 7.07B | 4.52% | 1,835,455 | - |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 6.87B | 4.67% | 562,365 | 569.61M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.58B | 1.00% | 1,483,395 | 1.55B |
| 142 | ERAS | Erasca, Inc. | 6.48B | 5.42% | 3,699,714 | - |
| 143 | CGON | CG Oncology, Inc. | 6.44B | 5.66% | 536,256 | 5.07M |
| 144 | BLLN | BillionToOne, Inc. | 6.42B | 5.34% | 515,395 | 354.54M |
| 145 | BLTE | Belite Bio, Inc | 6.28B | 4.80% | 241,880 | - |
| 146 | TXG | 10x Genomics, Inc. | 6.28B | 6.71% | 2,257,167 | 638.78M |
| 147 | PTCT | PTC Therapeutics, Inc. | 6.26B | 1.38% | 1,127,142 | 827.11M |
| 148 | HIMS | Hims & Hers Health, Inc. | 6.26B | 8.16% | 17,184,542 | 2.37B |
| 149 | XENE | Xenon Pharmaceuticals Inc. | 6.20B | 1.73% | 541,477 | 7.50M |
| 150 | DNTH | Dianthus Therapeutics, Inc. | 6.16B | 8.21% | 929,031 | 1.34M |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.10B | -3.36% | 946,544 | 840.85M |
| 152 | BLCO | Bausch + Lomb Corporation | 6.07B | 4.88% | 505,686 | 5.32B |
| 153 | DFTX | Definium Therapeutics, Inc. | 5.91B | 5.53% | 1,805,795 | - |
| 154 | ORKA | Oruka Therapeutics, Inc. | 5.90B | 11.12% | 1,439,683 | - |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.90B | -3.14% | 2,496,883 | 3.12B |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.87B | -0.14% | 2,098,831 | - |
| 157 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 2.87% | 283,317 | 274.48M |
| 158 | TFX | Teleflex Incorporated | 5.86B | -1.75% | 312,912 | 2.13B |
| 159 | HNGE | Hinge Health, Inc. | 5.81B | 1.42% | 961,379 | 646.34M |
| 160 | TWST | Twist Bioscience Corporation | 5.69B | 6.86% | 1,656,447 | 409.48M |
| 161 | STVN | Stevanato Group S.p.A. | 5.51B | -1.03% | 230,682 | 1.39B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.32B | 3.10% | 1,014,815 | 536.20M |
| 163 | MMED | MiniMed Group, Inc. | 5.10B | -1.39% | 821,338 | 3.10B |
| 164 | SHC | Sotera Health Company | 5.09B | 1.83% | 1,684,784 | 1.19B |
| 165 | MMSI | Merit Medical Systems, Inc. | 4.97B | 3.10% | 2,029,344 | 1.54B |
| 166 | RDNT | RadNet, Inc. | 4.93B | -1.07% | 524,382 | 2.14B |
| 167 | INDV | Indivior Pharmaceuticals, Inc. | 4.90B | 0.30% | 1,401,859 | 1.29B |
| 168 | DYN | Dyne Therapeutics, Inc. | 4.80B | 2.51% | 1,924,548 | - |
| 169 | CRSP | CRISPR Therapeutics AG | 4.77B | 1.68% | 1,376,609 | 4.10M |
| 170 | VCYT | Veracyte, Inc. | 4.77B | 7.31% | 1,542,033 | 541.74M |
| 171 | CAI | Caris Life Sciences, Inc. | 4.55B | 3.21% | 4,541,803 | 907.29M |
| 172 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | 0.80% | 1,298,574 | 1.10B |
| 173 | NVST | Envista Holdings Corporation | 4.52B | -2.08% | 2,160,759 | 2.81B |
| 174 | LIVN | LivaNova PLC | 4.45B | -0.47% | 645,768 | 1.43B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.42B | 3.45% | 809,036 | - |
| 176 | MANE | Veradermics, Incorporated | 4.37B | -2.90% | 613,727 | - |
| 177 | CELC | Celcuity Inc. | 4.27B | 5.26% | 1,322,498 | - |
| 178 | RLAY | Relay Therapeutics, Inc. | 4.24B | 5.88% | 1,609,769 | 10.68M |
| 179 | ICUI | ICU Medical, Inc. | 4.21B | 1.11% | 403,911 | 2.16B |
| 180 | LFST | LifeStance Health Group, Inc. | 4.17B | -1.10% | 1,903,066 | 1.49B |
| 181 | PBLS | Parabilis Medicines, Inc. | 4.11B | 1.57% | 394,837 | - |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 4.05B | 0.03% | 598,891 | 2.23B |
| 183 | WAY | Waystar Holding Corp. | 4.02B | -14.60% | 6,682,238 | 1.21B |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.99B | 6.65% | 1,435,726 | 56.99M |
| 185 | IRTC | iRhythm Holdings, Inc. | 3.91B | -2.74% | 728,445 | 787.85M |
| 186 | DNLI | Denali Therapeutics Inc. | 3.86B | 2.10% | 1,117,485 | - |
| 187 | HAE | Haemonetics Corporation | 3.85B | -0.70% | 473,129 | 1.33B |
| 188 | ALHC | Alignment Healthcare, Inc. | 3.85B | 1.75% | 4,058,762 | 4.26B |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 3.85B | 7.18% | 5,368,070 | 308.08M |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.84B | -0.96% | 3,178,315 | - |
| 191 | DOCS | Doximity, Inc. | 3.82B | -1.80% | 2,298,276 | 644.86M |
| 192 | ELVN | Enliven Therapeutics, Inc. | 3.77B | 1.85% | 647,726 | - |
| 193 | ALMS | Alumis Inc. | 3.69B | 9.74% | 992,164 | 8.40M |
| 194 | LEGN | Legend Biotech Corporation | 3.69B | 1.06% | 2,807,256 | 1.14B |
| 195 | NHC | National HealthCare Corporation | 3.58B | 0.14% | 133,743 | 1.53B |
| 196 | OGN | Organon & Co. | 3.56B | 0.07% | 1,522,996 | 6.16B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.55B | 6.81% | 638,034 | 236.00M |
| 198 | GPCR | Structure Therapeutics Inc. | 3.52B | 4.48% | 383,972 | - |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | 0.47% | 1,265,872 | 415.62M |
| 200 | BKD | Brookdale Senior Living Inc. | 3.49B | -1.62% | 4,654,595 | 3.00B |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.46B | 2.28% | 740,710 | 225.27M |
| 202 | ITGR | Integer Holdings Corporation | 3.42B | 1.04% | 314,127 | 1.86B |
| 203 | OPCH | Option Care Health, Inc. | 3.36B | -6.14% | 5,115,662 | 5.69B |
| 204 | TLX | Telix Pharmaceuticals Limited | 3.35B | -0.40% | 68,366 | 803.79M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 1.97% | 611,370 | 22.57M |
| 206 | WRBY | Warby Parker Inc. | 3.19B | -0.04% | 1,123,819 | 890.57M |
| 207 | MBX | MBX Biosciences, Inc. | 3.16B | 3.91% | 547,982 | - |
| 208 | GRAL | GRAIL, Inc. | 3.05B | 12.14% | 546,390 | 156.12M |
| 209 | IRON | Disc Medicine, Inc. | 3.03B | 7.52% | 374,863 | - |
| 210 | CLDX | Celldex Therapeutics, Inc. | 3.02B | 2.60% | 743,221 | 865.00K |
| 211 | PRVA | Privia Health Group, Inc. | 3.01B | -1.08% | 915,292 | 2.25B |
| 212 | RGC | Regencell Bioscience Holdings Limited | 2.94B | 5.13% | 163,573 | - |
| 213 | QURE | uniQure N.V. | 2.90B | 5.29% | 1,955,824 | 18.67M |
| 214 | XRAY | DENTSPLY SIRONA Inc. | 2.75B | -3.24% | 3,939,293 | 3.68B |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.75B | 1.69% | 454,757 | 229.58M |
| 216 | ATAI | AtaiBeckley Inc. | 2.66B | - | 14,879,032 | 3.49M |
| 217 | KOD | Kodiak Sciences Inc. | 2.65B | 6.22% | 628,857 | - |
| 218 | SUPN | Supernus Pharmaceuticals, Inc. | 2.65B | -2.06% | 345,899 | 776.83M |
| 219 | BEAM | Beam Therapeutics Inc. | 2.64B | 1.81% | 1,453,739 | 164.01M |
| 220 | TMDX | TransMedics Group, Inc. | 2.63B | -2.40% | 884,636 | 635.89M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.62B | 2.89% | 3,028,657 | 3.37B |
| 222 | IMNM | Immunome, Inc. | 2.61B | -0.13% | 595,409 | 4.02M |
| 223 | TRVI | Trevi Therapeutics, Inc. | 2.61B | 1.71% | 1,515,030 | - |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.61B | 0.51% | 152,209 | 1.46B |
| 225 | TARS | Tarsus Pharmaceuticals, Inc. | 2.56B | 1.74% | 699,098 | 535.08M |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 4.16% | 2,675,778 | 670.00M |
| 227 | NEOG | Neogen Corporation | 2.51B | 22.66% | 4,761,024 | 870.40M |
| 228 | PGNY | Progyny, Inc. | 2.47B | 0.38% | 696,717 | 1.29B |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -0.08% | 1,201,282 | 36.77M |
| 230 | VCEL | Vericel Corporation | 2.43B | 2.12% | 988,460 | 306.30M |
| 231 | PLSE | Pulse Biosciences, Inc. | 2.43B | 2.31% | 323,565 | 751.00K |
| 232 | NKTR | Nektar Therapeutics | 2.41B | 1.09% | 676,724 | 55.63M |
| 233 | VERA | Vera Therapeutics, Inc. | 2.37B | 1.66% | 2,056,378 | - |
| 234 | PHVS | Pharvaris N.V. | 2.37B | 3.86% | 512,501 | - |
| 235 | PBH | Prestige Consumer Healthcare Inc. | 2.37B | -4.29% | 309,266 | 1.09B |
| 236 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.35B | -3.04% | 2,322,501 | 885.72M |
| 237 | LMAT | LeMaitre Vascular, Inc. | 2.34B | -1.33% | 186,260 | 256.28M |
| 238 | NUVB | Nuvation Bio Inc. | 2.33B | 1.67% | 4,809,512 | 143.05M |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | -0.61% | 568,052 | - |
| 240 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.31B | 5.17% | 3,237,896 | -665.00K |
| 241 | CLOV | Clover Health Investments, Corp. | 2.29B | 2.60% | 2,514,379 | 2.21B |
| 242 | BHC | Bausch Health Companies Inc. | 2.25B | 28.85% | 18,649,827 | 10.85B |
| 243 | HTFL | HeartFlow, Inc. | 2.23B | 3.15% | 914,876 | 191.42M |
| 244 | AXGN | Axogen, Inc. | 2.22B | -0.05% | 1,394,641 | 251.17M |
| 245 | COAG | Hemab Therapeutics Holdings, Inc. | 2.22B | 6.08% | 820,846 | - |
| 246 | KLRA | Kailera Therapeutics, Inc. | 2.21B | 1.01% | 568,885 | - |
| 247 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 0.10% | 1,056,759 | 70.92M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.15B | 5.32% | 157,643 | - |
| 249 | BFLY | Butterfly Network, Inc. | 2.14B | 15.07% | 9,357,480 | 112.14M |
| 250 | ADUS | Addus HomeCare Corporation | 2.13B | -2.06% | 331,089 | 1.45B |
| 251 | MD | Pediatrix Medical Group, Inc. | 2.12B | -0.94% | 471,891 | 1.93B |
| 252 | PGEN | Precigen, Inc. | 2.12B | 8.99% | 3,589,037 | 31.60M |
| 253 | SION | Sionna Therapeutics, Inc. | 2.11B | 4.40% | 353,248 | - |
| 254 | AVAH | Aveanna Healthcare Holdings Inc. | 2.11B | -0.62% | 1,234,742 | 2.52B |
| 255 | IOVA | Iovance Biotherapeutics, Inc. | 2.09B | 2.85% | 14,051,831 | 285.61M |
| 256 | BHVN | Biohaven Ltd. | 2.08B | 2.90% | 1,242,479 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | - | 601,792 | 899.11M |
| 258 | NEO | NeoGenomics, Inc. | 2.07B | 3.99% | 5,303,192 | 766.30M |
| 259 | SGRY | Surgery Partners, Inc. | 2.06B | -3.11% | 1,138,373 | 3.34B |
| 260 | WGS | GeneDx Holdings Corp. | 2.05B | 8.28% | 841,237 | 442.68M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 2.05B | 4.49% | 216,870 | 20.00M |
| 262 | ZLAB | Zai Lab Limited | 2.05B | -0.55% | 306,755 | 453.28M |
| 263 | ATRC | AtriCure, Inc. | 2.04B | -1.81% | 906,804 | 569.62M |
| 264 | ZBIO | Zenas BioPharma, Inc. | 2.04B | 3.80% | 737,774 | 10.00M |
| 265 | SLS | SELLAS Life Sciences Group, Inc. | 2.02B | 1.88% | 3,776,825 | - |
| 266 | ADMA | ADMA Biologics, Inc. | 2.01B | -0.46% | 1,303,399 | 509.86M |
| 267 | URGN | UroGen Pharma Ltd. | 2.00B | 1.58% | 778,701 | 140.49M |
| 268 | NBTX | Nanobiotix S.A. | 1.98B | 6.09% | 151,844 | 38.27M |
| 269 | UFPT | UFP Technologies, Inc. | 1.98B | -0.02% | 178,246 | 608.85M |
| 270 | CDNA | CareDx, Inc. | 1.97B | 7.60% | 1,740,578 | 412.82M |
| 271 | TYRA | Tyra Biosciences, Inc. | 1.97B | 6.27% | 854,044 | - |
| 272 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -6.46% | 3,134,448 | 98.34M |
| 273 | GHRS | GH Research PLC | 1.95B | 1.43% | 388,848 | - |
| 274 | HCM | HUTCHMED (China) Limited | 1.94B | -5.44% | 59,659 | 548.51M |
| 275 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | -1.19% | 1,077,768 | 298.30M |
| 276 | GLUE | Monte Rosa Therapeutics, Inc. | 1.92B | 5.19% | 1,690,390 | 42.95M |
| 277 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.59% | 2,367,988 | - |
| 278 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | 4.72% | 3,387,653 | 7.47M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.88B | -1.45% | 425,707 | 367.34M |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.87B | 1.90% | 689,479 | 32.08M |
| 281 | MESO | Mesoblast Limited | 1.86B | 2.97% | 164,839 | 65.38M |
| 282 | OCUL | Ocular Therapeutix, Inc. | 1.85B | 1.32% | 2,686,425 | 52.04M |
| 283 | KARD | Kardigan, Inc. | 1.83B | 3.75% | 142,300 | - |
| 284 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -0.29% | 177,984 | 1.20B |
| 285 | FTRE | Fortrea Holdings Inc. | 1.81B | -6.47% | 1,949,371 | 2.68B |
| 286 | GENB | Generate Biomedicines, Inc. | 1.80B | 7.26% | 356,926 | 30.30M |
| 287 | DMRA | Damora Therapeutics, Inc. | 1.80B | 3.11% | 334,001 | - |
| 288 | NVCR | NovoCure Limited | 1.77B | 0.20% | 1,061,081 | 699.19M |
| 289 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.74B | 2.43% | 1,251,311 | 204.73M |
| 290 | ALMR | Alamar Biosciences, Inc. | 1.74B | 2.87% | 142,903 | 87.16M |
| 291 | ABCL | AbCellera Biologics Inc. | 1.74B | 5.57% | 4,095,700 | 79.21M |
| 292 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | 1.35% | 1,102,366 | 217.17M |
| 293 | BCAX | Bicara Therapeutics Inc. | 1.73B | 1.47% | 826,571 | - |
| 294 | IMCR | Immunocore Holdings plc | 1.72B | 1.35% | 213,118 | 412.81M |
| 295 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | -1.65% | 192,616 | 923.71M |
| 296 | OMCL | Omnicell, Inc. | 1.69B | -10.36% | 2,045,260 | 1.25B |
| 297 | ENOV | Enovis Corporation | 1.69B | -3.17% | 733,056 | 2.28B |
| 298 | TRAX | First Tracks Biotherapeutics, Inc. | 1.67B | 14.12% | 967,858 | - |
| 299 | ASTH | Astrana Health, Inc. | 1.65B | 0.47% | 329,251 | 3.53B |
| 300 | TRLV | Trulieve Cannabis Corp. | 1.65B | 6.33% | 1,244,788 | 1.17B |
| 301 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | 0.16% | 3,022,038 | 2.18B |
| 302 | ANAB | AnaptysBio, Inc. | 1.63B | 5.56% | 1,069,577 | 232.39M |
| 303 | ZYME | Zymeworks Inc. | 1.63B | 3.18% | 402,858 | 81.26M |
| 304 | AGL | agilon health, inc. | 1.61B | 4.41% | 145,763 | 5.82B |
| 305 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | 2.36% | 10,394,910 | 66.41M |
| 306 | AAPG | Ascentage Pharma Group International | 1.61B | -1.31% | 2,591 | 82.08M |
| 307 | XNCR | Xencor, Inc. | 1.59B | 10.04% | 1,615,274 | 97.36M |
| 308 | SEPN | Septerna, Inc. | 1.59B | 4.67% | 264,394 | 72.26M |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.58B | -1.49% | 598,714 | 1.86B |
| 310 | INNV | InnovAge Holding Corp. | 1.57B | 1.13% | 150,412 | 949.17M |
| 311 | MLTX | MoonLake Immunotherapeutics | 1.57B | 3.32% | 676,759 | - |
| 312 | INVA | Innoviva, Inc. | 1.57B | -1.94% | 508,588 | 420.69M |
| 313 | CMPS | COMPASS Pathways plc | 1.56B | 6.15% | 1,961,034 | - |
| 314 | NTLA | Intellia Therapeutics, Inc. | 1.55B | 2.69% | 3,180,574 | 66.09M |
| 315 | BLFS | BioLife Solutions, Inc. | 1.55B | 0.44% | 436,913 | 101.66M |
| 316 | ARDT | Ardent Health, Inc. | 1.54B | -1.83% | 397,174 | 6.43B |
| 317 | MAZE | Maze Therapeutics, Inc. | 1.53B | 1.32% | 335,018 | 20.00M |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.53B | 0.48% | 917,225 | 314.85M |
| 319 | VIR | Vir Biotechnology, Inc. | 1.50B | 3.01% | 1,197,340 | 65.50M |
| 320 | ATEC | Alphatec Holdings, Inc. | 1.49B | 0.10% | 1,811,312 | 787.08M |
| 321 | PAHC | Phibro Animal Health Corporation | 1.48B | -1.35% | 229,667 | 1.50B |
| 322 | HROW | Harrow, Inc. | 1.45B | 0.67% | 290,978 | 268.68M |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.44B | -2.06% | 576,449 | 915.25M |
| 324 | PNTG | The Pennant Group, Inc. | 1.43B | 0.12% | 179,080 | 1.02B |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.43B | 2.06% | 259,087 | - |
| 326 | PRGO | Perrigo Company plc | 1.43B | -1.15% | 2,282,706 | 4.18B |
| 327 | AHCO | AdaptHealth Corp. | 1.42B | -1.02% | 866,716 | 3.29B |
| 328 | CNMD | CONMED Corporation | 1.41B | 8.72% | 748,481 | 1.37B |
| 329 | SVRA | Savara Inc. | 1.40B | 4.92% | 1,240,732 | - |
| 330 | AHG | Akso Health Group | 1.36B | 8.90% | 5,065 | 13.83M |
| 331 | KMTS | Kestra Medical Technologies, Ltd. | 1.36B | 1.76% | 283,752 | 95.13M |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.35B | 0.03% | 451,127 | 3.42B |
| 333 | AORT | Artivion, Inc. | 1.34B | 0.44% | 592,039 | 458.69M |
| 334 | ETON | Eton Pharmaceuticals, Inc. | 1.34B | 1.87% | 603,882 | 86.93M |
| 335 | IART | Integra LifeSciences Holdings Corporation | 1.33B | 3.82% | 1,707,498 | 1.65B |
| 336 | AZTA | Azenta, Inc. | 1.33B | 1.84% | 616,109 | 596.48M |
| 337 | MNKD | MannKind Corporation | 1.31B | 6.75% | 4,129,907 | 360.78M |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.30B | 2.26% | 1,701,309 | 1.03B |
| 339 | AVLN | Avalyn Pharma Inc. | 1.30B | 4.31% | 118,569 | - |
| 340 | ABSI | Absci Corporation | 1.29B | 10.72% | 3,728,692 | 1.84M |
| 341 | PSNL | Personalis, Inc. | 1.29B | 4.69% | 2,742,767 | 64.52M |
| 342 | ALVO | Alvotech | 1.27B | 1.13% | 989,679 | 562.04M |
| 343 | AKTS | Aktis Oncology, Inc. | 1.27B | 2.72% | 331,086 | 8.28M |
| 344 | IMTX | Immatics N.V. | 1.26B | 2.34% | 1,607,922 | 43.00M |
| 345 | ARDX | Ardelyx, Inc. | 1.25B | 0.80% | 2,260,874 | 427.68M |
| 346 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 6.91% | 275,496 | 1.30M |
| 347 | NVAX | Novavax, Inc. | 1.22B | 1.36% | 2,378,372 | 596.34M |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.22B | 0.35% | 285,553 | 787.69M |
| 349 | IRMD | IRADIMED CORPORATION | 1.22B | 1.01% | 122,193 | 86.28M |
| 350 | CERT | Certara, Inc. | 1.21B | -3.83% | 5,163,392 | 419.75M |
| 351 | STAA | STAAR Surgical Company | 1.21B | 1.47% | 879,109 | 290.38M |
| 352 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | 3.19% | 1,874,746 | - |
| 353 | TDOC | Teladoc Health, Inc. | 1.20B | -28.32% | 25,481,047 | 2.49B |
| 354 | JBIO | Jade Biosciences, Inc. | 1.19B | 3.36% | 432,794 | - |
| 355 | VOR | Vor Biopharma Inc. | 1.18B | 11.51% | 800,186 | - |
| 356 | LBRX | LB Pharmaceuticals Inc | 1.17B | 4.87% | 513,939 | - |
| 357 | OMDA | Omada Health, Inc. | 1.17B | 0.41% | 1,143,092 | 283.30M |
| 358 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | -0.85% | 260,783 | 796.33M |
| 359 | SDGR | Schrödinger, Inc. | 1.15B | 1.52% | 880,064 | 254.91M |
| 360 | QDEL | QuidelOrtho Corporation | 1.13B | 0.42% | 1,124,203 | 2.66B |
| 361 | FRNM | Freenome, Inc. | 1.13B | -0.70% | 581,675 | 34.24M |
| 362 | ANRO | Alto Neuroscience, Inc. | 1.11B | 7.15% | 306,138 | - |
| 363 | MGTX | MeiraGTx Holdings plc | 1.11B | 3.10% | 458,025 | 79.76M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 1.15% | 963,009 | - |
| 365 | WVE | Wave Life Sciences Ltd. | 1.11B | -0.86% | 3,044,997 | 65.37M |
| 366 | BIOA | BioAge Labs, Inc. | 1.10B | 11.99% | 659,510 | 10.32M |
| 367 | BVS | Bioventus Inc. | 1.10B | 0.46% | 601,001 | 576.30M |
| 368 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 2.94% | 102,160 | - |
| 369 | CRON | Cronos Group Inc. | 1.08B | 1.05% | 800,376 | 159.54M |
| 370 | EYPT | EyePoint, Inc. | 1.08B | 7.89% | 1,560,318 | 7.61M |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 1.80% | 489,147 | - |
| 372 | DRTS | Alpha Tau Medical Ltd. | 1.07B | 6.35% | 606,126 | - |
| 373 | GDRX | GoodRx Holdings, Inc. | 1.07B | -1.55% | 2,073,218 | 787.89M |
| 374 | IVA | Inventiva S.A. | 1.07B | 2.44% | 694,621 | 7.94M |
| 375 | PCRX | Pacira BioSciences, Inc. | 1.06B | 2.16% | 558,244 | 734.86M |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 0.86% | 2,463,097 | 69.64M |
| 377 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 5.63% | 689,170 | - |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 2.00% | 935,219 | 59.00K |
| 379 | PRCT | PROCEPT BioRobotics Corporation | 1.02B | 0.67% | 1,057,741 | 322.02M |
| 380 | NUTX | Nutex Health Inc. | 1.02B | 5.85% | 169,940 | 879.95M |
| 381 | OPK | OPKO Health, Inc. | 996.35M | -2.20% | 2,847,433 | 587.90M |
| 382 | LMRI | Lumexa Imaging Holdings, Inc. | 984.83M | -0.49% | 384,578 | 1.03B |
| 383 | SANA | Sana Biotechnology, Inc. | 974.67M | 2.52% | 1,653,353 | - |
| 384 | GMRS | GMR Solutions Inc. | 972.95M | -3.17% | 122,707 | 5.83B |
| 385 | JANX | Janux Therapeutics, Inc. | 950.14M | 4.14% | 690,194 | 13.73M |
| 386 | AMPH | Amphastar Pharmaceuticals, Inc. | 898.61M | -0.97% | 355,683 | 720.53M |
| 387 | ODTX | Odyssey Therapeutics, Inc. | 881.91M | 2.05% | 106,838 | 1.06M |
| 388 | TBPH | Theravance Biopharma, Inc. | 873.31M | - | 398,141 | 109.78M |
| 389 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 981,515 | 238.37M |
| 390 | ABUS | Arbutus Biopharma Corporation | 871.14M | 2.80% | 786,234 | 191.45M |
| 391 | INMD | InMode Ltd. | 867.67M | -0.36% | 682,222 | 374.64M |
| 392 | ANNX | Annexon, Inc. | 863.45M | 8.44% | 2,612,645 | - |
| 393 | OMER | Omeros Corporation | 863.44M | 2.23% | 1,324,422 | 9.89M |
| 394 | GERN | Geron Corporation | 859.64M | -4.29% | 18,001,573 | 196.12M |
| 395 | GLAS | Glass House Brands Inc. | 842.25M | 5.21% | 318,321 | 177.68M |
| 396 | SLDB | Solid Biosciences Inc. | 835.84M | 5.60% | 845,867 | - |
| 397 | KURA | Kura Oncology, Inc. | 826.49M | 4.26% | 1,407,727 | 71.64M |
| 398 | HSTM | HealthStream, Inc. | 823.87M | -4.50% | 151,098 | 311.78M |
| 399 | DBVT | DBV Technologies S.A. | 812.86M | 0.58% | 658,409 | 5.04M |
| 400 | CSTL | Castle Biosciences, Inc. | 812.54M | 9.53% | 693,634 | 339.92M |
| 401 | AVR | Anteris Technologies Global Corp. | 803.03M | 4.30% | 1,437,833 | 1.85M |
| 402 | SSII | SS Innovations International, Inc. | 798.52M | 3.64% | 60,725 | 48.47M |
| 403 | SIBN | SI-BONE, Inc. | 797.84M | -2.44% | 476,069 | 206.22M |
| 404 | DSGN | Design Therapeutics, Inc. | 788.21M | 4.99% | 539,475 | - |
| 405 | AURA | Aura Biosciences, Inc. | 784.23M | 1.43% | 292,923 | - |
| 406 | TENX | Tenax Therapeutics, Inc. | 771.49M | 1.89% | 1,957,782 | - |
| 407 | MNPR | Monopar Therapeutics Inc. | 768.08M | 6.73% | 327,067 | - |
| 408 | SGP | SpyGlass Pharma, Inc. | 759.61M | 3.70% | 95,753 | - |
| 409 | ACRS | Aclaris Therapeutics, Inc. | 743.01M | 3.91% | 1,905,201 | 8.37M |
| 410 | FTH | Faeth Therapeutics, Inc. | 742.94M | -0.38% | 187,677 | - |
| 411 | CADL | Candel Therapeutics, Inc. | 723.18M | 5.00% | 873,643 | - |
| 412 | NVCT | Nuvectis Pharma, Inc. | 717.52M | 10.00% | 299,879 | - |
| 413 | PHAT | Phathom Pharmaceuticals, Inc. | 717.25M | -22.42% | 7,618,222 | 239.66M |
| 414 | CTMX | CytomX Therapeutics, Inc. | 714.07M | 3.47% | 1,489,590 | 35.54M |
| 415 | PHAR | Pharming Group N.V. | 712.11M | -10.49% | 49,553 | 366.48M |
| 416 | EVO | Evotec SE | 706.41M | - | 43,924 | 859.03M |
| 417 | RIGL | Rigel Pharmaceuticals, Inc. | 704.19M | -2.59% | 216,079 | 299.77M |
| 418 | DRUG | Bright Minds Biosciences Inc. | 693.64M | 5.02% | 207,012 | - |
| 419 | CLYM | Climb Bio, Inc. | 691.71M | -0.25% | 1,799,155 | - |
| 420 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 680.91M | 3.22% | 293,362 | - |
| 421 | ALLO | Allogene Therapeutics, Inc. | 679.95M | 8.84% | 10,045,974 | 22.00K |
| 422 | OCS | Oculis Holding AG | 676.95M | 3.41% | 474,619 | 1.40M |
| 423 | NGNE | Neurogene Inc. | 669.54M | -0.18% | 93,077 | 925.00K |
| 424 | CBLL | CeriBell, Inc. | 669.31M | -0.51% | 387,666 | 95.07M |
| 425 | PHR | Phreesia, Inc. | 655.82M | -4.76% | 900,490 | 495.59M |
| 426 | GYRE | Gyre Therapeutics, Inc. | 647.75M | 3.01% | 45,636 | 117.05M |
| 427 | ACHV | Achieve Life Sciences, Inc. | 646.75M | 2.02% | 828,974 | - |
| 428 | MPLT | MapLight Therapeutics, Inc. | 636.20M | -6.59% | 3,153,784 | - |
| 429 | TCMD | Tactile Systems Technology, Inc. | 636.09M | 2.92% | 252,772 | 343.52M |
| 430 | MDXG | MiMedx Group, Inc. | 636.00M | 0.95% | 5,706,104 | 355.17M |
| 431 | BBNX | Beta Bionics, Inc. | 635.90M | -5.93% | 3,195,737 | 119.01M |
| 432 | AGMB | AgomAb Therapeutics NV | 628.16M | 2.86% | 68,899 | - |
| 433 | RGNX | REGENXBIO Inc. | 624.43M | 5.20% | 1,215,089 | 87.82M |
| 434 | CBIO | Crescent Biopharma, Inc. | 620.68M | 1.69% | 282,827 | 11.88M |
| 435 | BWAY | BrainsWay Ltd. | 617.46M | 7.70% | 82,210 | 56.22M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 614.01M | 4.78% | 1,299,348 | 361.51M |
| 437 | ANGO | AngioDynamics, Inc. | 610.48M | 0.96% | 399,056 | 320.17M |
| 438 | IMMX | Immix Biopharma, Inc. | 608.67M | 4.65% | 1,297,097 | - |
| 439 | CTNM | Contineum Therapeutics, Inc. | 588.84M | 9.53% | 337,655 | - |
| 440 | CRMD | CorMedix Inc. | 587.60M | 4.17% | 1,036,535 | 400.05M |
| 441 | ALT | Altimmune, Inc. | 579.53M | 2.05% | 5,437,195 | 36.00K |
| 442 | CERS | Cerus Corporation | 579.07M | 0.70% | 1,947,327 | 216.56M |
| 443 | FLGT | Fulgent Genetics, Inc. | 573.98M | 2.90% | 215,199 | 320.35M |
| 444 | ZVRA | Zevra Therapeutics, Inc. | 569.87M | -1.43% | 1,911,559 | 122.29M |
| 445 | RLMD | Relmada Therapeutics, Inc. | 561.16M | 4.09% | 940,040 | - |
| 446 | SPRY | ARS Pharmaceuticals, Inc. | 559.08M | -3.43% | 1,626,742 | 98.99M |
| 447 | CTKB | Cytek Biosciences, Inc. | 556.60M | -1.60% | 525,927 | 204.17M |
| 448 | STTK | Shattuck Labs, Inc. | 551.33M | 6.36% | 681,623 | 1.00M |
| 449 | TLRY | Tilray Brands, Inc. | 550.59M | 5.26% | 7,840,758 | 915.45M |
| 450 | SLN | Silence Therapeutics plc | 548.86M | 0.61% | 769,513 | 839.00K |
| 451 | PRME | Prime Medicine, Inc. | 545.46M | -0.33% | 2,160,822 | 4.03M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 537.96M | 0.28% | 185,474 | - |
| 453 | VSTM | Verastem, Inc. | 536.03M | 1.50% | 1,277,655 | 49.59M |
| 454 | ARVN | Arvinas, Inc. | 535.53M | 0.97% | 549,670 | 89.40M |
| 455 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.48M | 6.17% | 513,874 | 151.40M |
| 456 | FDMT | 4D Molecular Therapeutics, Inc. | 526.42M | 4.79% | 384,741 | 88.24M |
| 457 | ZURA | Zura Bio Limited | 526.29M | 4.33% | 409,589 | - |
| 458 | WEAV | Weave Communications, Inc. | 521.95M | -5.61% | 704,232 | 248.72M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 520.81M | 6.77% | 268,303 | - |
| 460 | ANL | Adlai Nortye Ltd. | 520.00M | 7.35% | 157,640 | 5.00M |
| 461 | KIDS | OrthoPediatrics Corp. | 516.53M | 0.60% | 119,999 | 243.30M |
| 462 | RZLT | Rezolute, Inc. | 509.80M | 3.83% | 805,797 | - |
| 463 | MYGN | Myriad Genetics, Inc. | 507.19M | 6.55% | 2,103,131 | 829.00M |
| 464 | TOI | The Oncology Institute, Inc. | 506.91M | 6.29% | 1,238,944 | 545.76M |
| 465 | ARTV | Artiva Biotherapeutics, Inc. | 506.77M | 4.09% | 230,808 | 251.00K |
| 466 | HELP | Cybin Inc. | 504.55M | 2.91% | 862,149 | - |
| 467 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 468 | ASMB | Assembly Biosciences, Inc. | 501.68M | 3.78% | 55,716 | 71.10M |
| 469 | PRLD | Prelude Therapeutics Incorporated | 500.85M | 7.22% | 329,679 | 16.72M |
| 470 | SOPH | SOPHiA GENETICS SA | 483.24M | 3.78% | 182,398 | 81.18M |
| 471 | SI | Shoulder Innovations, Inc. | 480.92M | -2.23% | 96,340 | 53.89M |
| 472 | PROK | ProKidney Corp. | 477.25M | 2.60% | 662,209 | 889.00K |
| 473 | OFIX | Orthofix Medical Inc. | 476.57M | -3.12% | 242,417 | 825.37M |
| 474 | VALN | Valneva SE | 472.70M | 0.32% | 12,181 | 180.25M |
| 475 | NNNN | Anbio Biotechnology | 471.83M | -7.25% | 120,178 | 8.65M |
| 476 | NPCE | NeuroPace, Inc. | 468.79M | 0.81% | 229,132 | 99.53M |
| 477 | AQST | Aquestive Therapeutics, Inc. | 466.74M | 3.33% | 1,446,109 | 50.27M |
| 478 | VREX | Varex Imaging Corporation | 466.56M | 1.10% | 221,254 | 857.50M |
| 479 | QTTB | Q32 Bio Inc. | 463.13M | 6.28% | 529,901 | 53.74M |
| 480 | PACB | Pacific Biosciences of California, Inc. | 459.69M | 5.71% | 2,806,815 | 160.03M |
| 481 | KYTX | Kyverna Therapeutics, Inc. | 455.36M | 5.94% | 642,415 | - |
| 482 | SGMT | Sagimet Biosciences Inc. | 451.41M | 3.84% | 389,790 | - |
| 483 | REPL | Replimune Group, Inc. | 450.89M | -0.74% | 3,415 | - |
| 484 | VMD | Viemed Healthcare, Inc. | 450.84M | 0.94% | 210,211 | 286.57M |
| 485 | IKT | Inhibikase Therapeutics, Inc. | 445.56M | 3.17% | 402,578 | 1.00 |
| 486 | CABA | Cabaletta Bio, Inc. | 443.51M | 3.82% | 1,293,342 | - |
| 487 | OVID | Ovid Therapeutics Inc. | 442.34M | 3.49% | 1,286,171 | 7.12M |
| 488 | SRTA | Strata Critical Medical, Inc. | 440.42M | 4.52% | 1,321,332 | 228.58M |
| 489 | PRTA | Prothena Corporation plc | 440.29M | -1.75% | 502,233 | 57.94M |
| 490 | CLPT | ClearPoint Neuro, Inc. | 437.25M | 3.11% | 438,808 | 40.61M |
| 491 | SLBT | SL Science Holding Limited | 434.77M | 3.46% | 42,855 | 3.36M |
| 492 | OCGN | Ocugen, Inc. | 426.54M | 5.88% | 3,105,985 | 4.47M |
| 493 | NRC | NRC Health | 418.65M | 3.33% | 140,785 | 140.00M |
| 494 | DCTH | Delcath Systems, Inc. | 415.64M | 3.97% | 306,817 | 90.44M |
| 495 | EDIT | Editas Medicine, Inc. | 412.81M | 3.46% | 833,835 | 38.69M |
| 496 | STRO | Sutro Biopharma, Inc. | 411.28M | 6.43% | 148,324 | 99.61M |
| 497 | VTVT | vTv Therapeutics Inc. | 409.20M | 3.81% | 65,662 | 36.84M |
| 498 | EVMN | Evommune, Inc. | 408.81M | 2.71% | 357,415 | 10.00M |
| 499 | BNTC | Benitec Biopharma Inc. | 407.44M | -1.58% | 44,757 | - |
| 500 | AUTL | Autolus Therapeutics plc | 407.20M | 4.79% | 1,743,718 | 92.62M |